BEDMINSTER, N.J., March 26, 2018 (GLOBE NEWSWIRE) — Matinas Biopharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today formally announced its financial results for the year ended December 31, 2017. “During 2017, we made solid progress in our clinical development and the understanding of our proprietary […]
This post first appeared on Bloggerwave Inc. Is In The StockGuru Spotlight For October 22, 2010 | StockGuru SmallCap Alerts On Penny Stocks, please read the originial post: here
